Risk Prediction Model for Early Hodgkin's Lymphoma Outperforms Widely Used Standard

(MedPage Today) — A prognostication tool for early classic Hodgkin’s lymphoma (cHL) outperformed a widely used classification system in predicting 2-year progression-free survival (PFS), according to training and validation studies involving more…

Source link : https://www.medpagetoday.com/hematologyoncology/lymphoma/116247

Author :

Publish date : 2025-06-25 19:03:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Risk Prediction Model for Early Hodgkin’s Lymphoma Outperforms Widely Used Standard

Gastric bypass surgery may cut the risk of bowel cancer

New and Improved Navitor Makes for a Serious TAVR Contender

Related Posts

Novel Drug Lowers Urate Levels but Gout Flares Persist

Loneliness Not Tied to Mortality in Older Adult Home Care

Trimodal Therapy Costs Offset QOL Benefit in Bladder Cancer

US Neonatal Mortality Rate: Unveiling the Perinatal Causes

Womb lining test offers miscarriage hope to women

CDC Experts Make the Case for Maternal COVID Vaccination

Novel Drug Lowers Urate Levels but Gout Flares Persist

Loneliness Not Tied to Mortality in Older Adult Home Care

Trimodal Therapy Costs Offset QOL Benefit in Bladder Cancer

US Neonatal Mortality Rate: Unveiling the Perinatal Causes

Womb lining test offers miscarriage hope to women

CDC Experts Make the Case for Maternal COVID Vaccination

HHS Hunts for New Autism Links While David Geier Searches for ‘Lost’ Vaccine Data

CDC Director Nominee Faces Tough Questions at Senate Hearing

Categories

Archives